VEGFA and blindness (disorder): Age-related macular degeneration (AMD) is a leading cause of blindness [7, 8], although recent progress in anti-vascular endothelial growth factor (anti-VEGF) therapy has substantially improved the visual prognosis of one AMD subtype, namely, wet AMD [9–11].